SCHEMBL28517261

SCHEMBL28517261

C[C@H]1CN(C)CCN1c1ccc(-c2cc(Br)c[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.38
GSK3B P49841 2/20 0.37
MAPK1 P28482 2/20 0.34
MAPT P10636 3/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
HSF1 Q00613 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
TRPV4 Q9HBA0 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MELK Q14680 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
PDE3B Q13370 1/20 0.30
PDE3A Q14432 1/20 0.30
DRD2 P14416 1/20 0.30
PIK3C3 Q8NEB9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28517264 1.00 HRH3 (0.38) HRH3GSK3BMAPK1MAPTCCNE1
SCHEMBL21590149 0.79 HRH3 (0.51) HRH3GSK3BMAPK1MAPTCCNE1
SCHEMBL21590190 0.79 HRH3 (0.51) HRH3GSK3BMAPK1MAPTCCNE1
SCHEMBL21590260 0.79 HRH3 (0.51) HRH3GSK3BMAPK1MAPTCCNE1
SCHEMBL28499871 0.78 MELK (0.49) MAPTKDM4EMELKHRH4PDE3B
SCHEMBL28510928 0.77 MAPK1 (0.39) HRH3GSK3BMAPK1CCNE1CDK2
SCHEMBL28510930 0.77 MAPK1 (0.39) HRH3GSK3BMAPK1CCNE1CDK2
SCHEMBL19003699 0.71 SMN1; SMN2 (0.47) HRH3GSK3BMAPK1MAPTLMNA
SCHEMBL2610122 0.71 SMN1; SMN2 (0.47) HRH3GSK3BMAPK1MAPTLMNA
SCHEMBL27372185 0.71 SMN1; SMN2 (0.47) HRH3GSK3BMAPK1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed